SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation has announced the placement of BioMark™ Real-time PCR Systems in high-profile R&D organizations. Among recent adopters are MedImmune, Inc., in Gaithersburg, Maryland; Eisai Co., Ltd., in Tokyo, Japan; and the laboratory of Dr. Stephen Quake, a Howard Hughes Medical Research Institute lab, at Stanford University, in Stanford, California.
